Differential Expression of <i>BOC</i>, <i>SPOCK2</i>, and <i>GJD3</i> Is Associated with Brain Metastasis of ER-Negative Breast Cancers

Background: Brain metastasis is considered one of the major causes of mortality in breast cancer patients. To invade the brain, tumor cells need to pass the blood-brain barrier by mechanisms that are partially understood. In primary ER-negative breast cancers that developed brain metastases, we foun...

Full description

Bibliographic Details
Main Authors: Rute M. S. M. Pedrosa, Leonoor V. Wismans, Renata Sinke, Marcel van der Weiden, Casper H. J. van Eijck, Johan M. Kros, Dana A. M. Mustafa
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/12/2982
Description
Summary:Background: Brain metastasis is considered one of the major causes of mortality in breast cancer patients. To invade the brain, tumor cells need to pass the blood-brain barrier by mechanisms that are partially understood. In primary ER-negative breast cancers that developed brain metastases, we found that some of the differentially expressed genes play roles in the T cell response. The present study aimed to identify genes involved in the formation of brain metastasis independently from the T cell response. Method: Previously profiled primary breast cancer samples were reanalyzed. Genes that were found to be differentially expressed were confirmed by RT-PCR and by immunohistochemistry using an independent cohort of samples. Results: <i>BOC, SPOCK2,</i> and <i>GJD3</i> were overexpressed in the primary breast tumors that developed brain metastasis. <i>BOC</i> expression was successfully validated at the protein level. <i>SPOCK2</i> was validated at both mRNA and protein levels. <i>SPOCK2</i> and <i>GJD3</i> mRNA overexpression were also found to be associated with cerebral metastasis in an external online database consisting of 204 primary breast cancers. Conclusion: The overexpression of <i>BOC, SPOCK2</i>, and <i>GJD3</i> is associated with the invasion of breast cancer into the brain. Further studies to determine their specific function and potential value as brain metastasis biomarkers are required.
ISSN:2072-6694